Dimension Bio CEO Caralynn Nowinski Collens, M.D., joined the “Prime Movers” podcast this month to discuss her company’s mission to create life-saving regenerative therapies.
She shares her journey in the startup world, the increasing demand for liver treatments, and the innovative approaches Dimension Bio is taking with cell-based therapies. The conversation also touches on recent advancements, regulatory challenges, and future predictions for the field of regenerative medicine.
Be sure to follow “Prime Movers” on Apple Podcasts or Spotify and subscribe to watch the entire conversation on YouTube below:
<a href="https://medium.com/media/8bafb5cc27f61aeaf2b16142954222ff/href">https://medium.com/media/8bafb5cc27f61aeaf2b16142954222ff/href</a>
Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who transform billions of lives. We invest in companies reinventing energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture.
Sign up here if you are not already subscribed to our blog.
Listen to the Latest Episode of “Prime Movers” with Dimension Bio CEO Caralynn Nowinski Collens was originally published in Prime Movers Lab on Medium, where people are continuing the conversation by highlighting and responding to this story.